The p-value of the H-L test was beyond 0.05.<h4>Conclusions</h4>A prediction model combining radiomic features and clinicopathological characteristics could be a promising approach to predict the expression of AR and noninvasively screen the BC patients who could benefit from anti-AR regimens. The gene discussed is AR; the disease is breast cancer.